We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

151 hedge funds and large institutions have $221M invested in BioDelivery Sciences International, Inc. in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more call options, than puts

Call options by funds: $4.02M | Put options by funds: $1.64M

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

20% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 45

6% more funds holding

Funds holding: 143151 (+8)

5% more capital invested

Capital invested by funds: $210M → $221M (+$11.4M)

Holders
151
Holders Change
+8
Holders Change %
+5.59%
% of All Funds
2.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
54
Reduced
45
Closed
9
Calls
$4.02M
Puts
$1.64M
Net Calls
+$2.38M
Net Calls Change
-$603K
Name Holding Trade Value Shares
Change
Change in
Stake
Lazard Asset Management
101
Lazard Asset Management
New York
$84K -$2.55K -676 -3%
MLICM
102
Metropolitan Life Insurance Company (MetLife)
New York
$82.9K +$41.6K +11,021 +92%
ASRS
103
Arizona State Retirement System
Arizona
$82K -$2.05K -544 -2%
MAM
104
Meeder Asset Management
Ohio
$79K
CSS
105
Cubist Systematic Strategies
Connecticut
$77K +$6.4K +1,697 +9%
DT
106
Diversified Trust
Tennessee
$71K -$2.49K -659 -3%
ACI
107
AMP Capital Investors
Australia
$67K
BNP Paribas Financial Markets
108
BNP Paribas Financial Markets
France
$63.8K +$55.1K +14,619 +478%
ECM
109
ExodusPoint Capital Management
New York
$62K -$13.1K -3,464 -17%
AB
110
Amalgamated Bank
New York
$61K -$2.61K -692 -4%
Citadel Advisors
111
Citadel Advisors
Florida
$58K +$60.6K +16,075 New
Prudential Financial
112
Prudential Financial
New Jersey
$51K -$3.76K -997 -7%
CNC
113
Canandaigua National Corp
New York
$51K +$377 +100 +0.7%
Teacher Retirement System of Texas
114
Teacher Retirement System of Texas
Texas
$50K +$10.3K +2,736 +25%
VRS
115
Virginia Retirement Systems
Virginia
$49K +$3.4K +900 +7%
Mackenzie Financial
116
Mackenzie Financial
Ontario, Canada
$49K +$51.5K +13,651 New
Credit Agricole
117
Credit Agricole
France
$47K -$45.3K -12,000 -48%
Zurich Cantonal Bank
118
Zurich Cantonal Bank
Switzerland
$46K
PAG
119
Private Advisor Group
New Jersey
$39K +$40.7K +10,800 New
Osaic Holdings
120
Osaic Holdings
Arizona
$36K -$24.7K -6,546 -39%
SI
121
Stephens Inc
Arkansas
$36K
SM
122
SG3 Management
Puerto Rico
$36K +$37.7K +10,000 New
Royal Bank of Canada
123
Royal Bank of Canada
Ontario, Canada
$29K +$6.25K +1,656 +25%
HI
124
Harbour Investments
Wisconsin
$28K
CAM
125
Close Asset Management
United Kingdom
$27K

BDSI Hedge Fund Activity: Q3 2021 in Review

151 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2021, worth a combined $221M — up 5.4% from $210M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BDSI positions and 9 closed out — a net gain of 8 holders — while 54 added to existing stakes and 45 trimmed.

The largest buyer was LSV Asset Management, opening a new position worth an estimated $7.26M. The largest seller was Goldman Sachs, cutting an estimated $5.33M.

  • 151 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2021, up from 143 in Q2 2021.
  • Funds reported $221M of BioDelivery Sciences International, Inc. stock for Q3 2021, up 5.4% quarter-over-quarter.
  • 17 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2021 and 9 closed out, a net change of +8 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2021 was LSV Asset Management, an estimated $7.26M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2021 was Goldman Sachs, an estimated $5.33M sold.

Based on aggregated 13F filings for Q3 2021.